United Kingdom · Question · Written question
HL HL1634
Innovative Medicines Fund
Introduced
3 July 2026
Last action
15 July 2026 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
15 July 2026
Summary
To ask His Majesty's Government how many of the protocols under evaluation by the Clinical Priorities Advisory Group since 2024 were deferred to consideration in a future year; why any such deferrals were necessary; and what steps they are taking to ensur
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
3 July 2026
Written question
To ask His Majesty's Government how many of the protocols under evaluation by the Clinical Priorities Advisory Group since 2024 were deferred to consideration in a future year; why any such deferrals were necessary; and what steps they are taking to ensur
Source: Lords
15 July 2026
Answer
There were eight policy propositions at the Clinical Priorities Advisory Group (CPAG) Prioritisation Meeting in May 2024 that were not commissioned due to insufficient resource, with further information available at the NHS.UK website.CPAG makes recommend...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2026-07-03/HL1634
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1924097
- uk · wq-1924097 · source updated 15 July 2026